BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer

NCT00540800 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

139

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: docetaxel
DRUG: epirubicin
DRUG: capecitabine

Sponsor

National Cancer Institute, Naples